How common is PKAN disease?

Table of Contents

PKAN affects males and females in equal numbers. The symptoms typically develop during childhood, although occasionally they begin during late adolescence or adulthood. Cases in infancy and of adult onset have also been reported. The frequency of PKAN is estimated to be one to three per million individuals worldwide.

What is Hallervorden Spatz syndrome?

Hallervorden–Spatz syndrome is an autosomal recessive disorder characterized by dystonia, parkinsonism, and iron accumulation in the brain. Many patients with this disease have mutations in the gene encoding pantothenate kinase 2 (PANK2); these patients are said to have pantothenate kinase–associated neurodegeneration.

What is NBIA?

Neurodegeneration with brain iron accumulation (NBIA) is a rare, inherited, neurological movement disorder characterized by an abnormal accumulation of iron in the brain and progressive degeneration of the nervous system.

Is there a cure for PKAN?

There is currently no established therapy for the disease. Intrathecal baclofen has been reported to improve ease of care and dystonia in PKAN patients. Deferiprone, an iron chelator, has been shown to be safe and tolerable in PKAN patients, as well as effective in reducing brain iron accumulation as measured by MRI.

What causes PKAN disease?

Disease at a Glance A particular change, called the eye-of-the-tiger sign, which indicates a buildup of iron, is typically seen on magnetic resonance imaging (MRI) scans of the brain in people with this disorder. PKAN is inherited in an autosomal recessive manner and is caused by genetic changes in the PANK2 gene.

How is NBIA treated?

There is no specific treatment for NBIA. Medicines that bind iron may help slow the disease. Treatment is mainly focused on controlling the symptoms. The most commonly used medicines to control symptoms include baclofen and trihexyphenidyl.

What causes iron deposit brain?

Mutations of the CP gene result in deficient levels of functional ceruloplasmin, which ultimately results in the accumulation of iron in the brain and other organs of the body. Iron accumulation damages the tissue of affected organs causing the characteristic symptoms of aceruloplasminemia.

What causes iron deposits in the brain?

What is Aceruloplasminemia?

Aceruloplasminemia is a rare genetic disorder characterized by the abnormal accumulation of iron in the brain and various internal organs. Affected individuals develop neurological symptoms including cognitive impairment and movement disorders. Degeneration of the retina and diabetes may also occur.

What is pantothenate kinase associated neurodegeneration?

Pantothenate kinase-associated neurodegeneration (formerly called Hallervorden-Spatz syndrome) is a disorder of the nervous system. This condition is characterized by progressive difficulty with movement, typically beginning in childhood.

Is Aceruloplasminemia curable?

Aceruloplasminemia is a rare and secondary cause of movement disorder that is potentially treatable. The neurological findings play an important role by prompting the diagnosis. FFP and iron chelation therapy seem to have an impact on the clinical and imaging progression of the disease.

Does hemochromatosis affect the brain?

Hereditary hemochromatosis (HH), characterized by systemic iron loading, usually does not involve the CNS, and only sporadic cases of neurological abnormalities or brain-MRI T2/T2*GRE-hypointensity have been reported.

What is pantothenate used for?

Pantothenate is vitamin B5. Vitamins are naturally occurring substances necessary for many processes in the body. Pantothenate is important for the breakdown of the foods we eat into substances the body can use. Pantothenate is also important in the creation of hormones and other substances in the body.

What is the function of pantothenate kinase?

Pantothenate kinase (PANK) is a metabolic enzyme that regulates cellular coenzyme A (CoA) levels. There are three human PANK genes, and inactivating mutations in PANK2 lead to pantothenate kinase associated neurodegeneration (PKAN). Here we performed a library screen followed by chemical optimizatio …

Is pantothenate kinase-associated neurodegeneration (PKAN) autosomal recessive or dominant?

Mode of Inheritance Pantothenate kinase-associated neurodegeneration (PKAN) is inherited in an autosomal recessivemanner. Risk to Family Members

What happens if the PANK2 gene is altered?

Mutations in the PANK2 gene likely result in the production of an abnormal version of pantothenate kinase 2 or prevent cells from making any of this enzyme. A lack of functional pantothenate kinase 2 disrupts the production of coenzyme A and allows potentially harmful compounds to build up in the brain.